Home > Cashflow Statement > CORONA REMEDIES

CORONA REMEDIES
Cashflow Statement

CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Profit Before Tax₹240 Cr₹199 Cr₹118 Cr₹111 Cr
Adjustment ₹44 Cr₹52 Cr₹47 Cr₹23 Cr
Changes In working Capital ₹-5.87 Cr₹-17 Cr₹9.32 Cr₹-4.92 Cr
Cash Flow after changes in Working Capital ₹279 Cr₹234 Cr₹175 Cr₹129 Cr
Cash Flow from Operating Activities ₹229 Cr₹190 Cr₹157 Cr₹103 Cr
Cash Flow from Investing Activities ₹-256 Cr₹-84 Cr₹-267 Cr₹-50 Cr
Cash Flow from Financing Activities ₹25 Cr₹-107 Cr₹99 Cr₹-45 Cr
Net Cash Inflow / Outflow ₹-1.39 Cr₹0.06 Cr₹-11 Cr₹7.71 Cr
Opening Cash & Cash Equivalents ₹3.22 Cr₹3.16 Cr₹14 Cr₹6.82 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ----
Cash & Cash Equivalent of Subsidiaries under liquidations ----
Translation adjustment on reserves / op cash balalces frgn subsidiaries ----
Effect of Foreign Exchange Fluctuations --₹0.00 Cr₹-0.04 Cr
Closing Cash & Cash Equivalent ₹1.83 Cr₹3.22 Cr₹3.16 Cr₹14 Cr

Compare Cashflow Statement of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,289.3 Cr 5.2% 3.3% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,202.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹264,141.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,402.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹111,868.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,650.0 Cr 2% -0.2% -14.3% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

5.2%

3.3%

NA
SENSEX

2.8%

4.4%

-10.1%


You may also like the below Video Courses